Trial · NCT03197662
Adverse events52
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 52
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 0 | 15 | 0 |
| other | Fatigue | General disorders | Placebo Comparator: Matched Placebo | 3 | 17 | 3 |
| other | Increased Irritability | Psychiatric disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 0 | 15 | 0 |
| other | Increased Irritability | Psychiatric disorders | Placebo Comparator: Matched Placebo | 2 | 17 | 2 |
| other | Headache | Nervous system disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 2 | 15 | 2 |
| other | Headache | Nervous system disorders | Placebo Comparator: Matched Placebo | 3 | 17 | 3 |
| other | Nausea | Gastrointestinal disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 0 | 15 | 0 |
| other | Nausea | Gastrointestinal disorders | Placebo Comparator: Matched Placebo | 1 | 17 | 1 |
| other | Aggressive Episode | Psychiatric disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 1 | 15 | 1 |
| other | Aggressive Episode | Psychiatric disorders | Placebo Comparator: Matched Placebo | 0 | 17 | 0 |
| other | Nasal Congestion | Respiratory, thoracic and mediastinal disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 2 | 15 | 2 |
| other | Nasal Congestion | Respiratory, thoracic and mediastinal disorders | Placebo Comparator: Matched Placebo | 0 | 17 | 0 |
| other | Strep Throat | Infections and infestations | Experimental: Intranasal Oxytocin (IN-OXT) | 0 | 15 | 0 |
| other | Strep Throat | Infections and infestations | Placebo Comparator: Matched Placebo | 1 | 17 | 1 |
| other | Nasal Irritation | Respiratory, thoracic and mediastinal disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 1 | 15 | 1 |
| other | Nasal Irritation | Respiratory, thoracic and mediastinal disorders | Placebo Comparator: Matched Placebo | 1 | 17 | 1 |
| other | Rash - Upper Arms | Skin and subcutaneous tissue disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 1 | 15 | 1 |
| other | Rash - Upper Arms | Skin and subcutaneous tissue disorders | Placebo Comparator: Matched Placebo | 0 | 17 | 0 |
| other | Increased Episodes of Crying | Psychiatric disorders | Experimental: Intranasal Oxytocin (IN-OXT) | 1 | 15 | 1 |
| other | Increased Episodes of Crying | Psychiatric disorders | Placebo Comparator: Matched Placebo | 1 | 17 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197662/events